Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma
PeerJ · 2024
DOI: 10.7717/peerj.17296 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Peiyang Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Oral Me…. Hauptthemen laut MEDLINE: Pyroptosis, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, West China School/Hospital of Stomatology Sichuan University, Postdoctoral Research Funding of Sichuan University.
Abstract (Originalsprache)
Background
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers. Chemotherapy remains one dominant therapeutic strategy, while a substantial proportion of patients may develop chemotherapeutic resistance; therefore, it is particularly significant to identify the patients who could achieve maximum benefits from chemotherapy. Presently, four pyroptosis genes are reported to correlate with the chemotherapeutic response or prognosis of HNSCC, while no study has assessed the combinatorial predicting efficacy of these four genes. Hence, this study aims to evaluate the predictive value of a multi-gene pyroptosis model regarding the prognosis and chemotherapeutic responsiveness in HNSCC.
Methods
By utilizing RNA-sequencing data from The Cancer Genome Atlas database and the Gene Expression Omnibus database, the pyroptosis-related gene score (PRGscore) was computed for each HNSCC sample by performing a Gene Set Variation Analysis (GSVA) based on four genes (Caspase-1, Caspase-3, Gasdermin D, Gasdermin E). The prognostic significance of the PRGscore was assessed through Cox regression and Kaplan–Meier survival analyses. Additionally, chemotherapy sensitivity stratified by high and low PRGscore was examined to determine the potential association between pyroptosis activity and chemosensitivity. Furthermore, chemotherapy sensitivity assays were conducted in HNSCC cell lines in vitro .
Results
As a result, our study successfully formulated a PRGscore reflective of pyroptotic activity in HNSCC. Higher PRGscore correlates with worse prognosis. However, patients with higher PRGscore were remarkably more responsive to chemotherapy. In agreement, chemotherapy sensitivity tests on HNSCC cell lines indicated a positive association between overall pyroptosis levels and chemosensitivity to cisplatin and 5-fluorouracil; in addition, patients with higher PRGscore may benefit from the immunotherapy. Overall, our study suggests that HNSCC patients with higher PRGscore, though may have a less favorable prognosis, chemotherapy and immunotherapy may exhibit better benefits in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengd…
Förderung
- National Natural Science Foundation of China
- West China School/Hospital of Stomatology Sichuan University
- Postdoctoral Research Funding of Sichuan University
- Research and Develop Program of West China Hospital of Stomatology of Sichuan University
- Key Research Program of Sichuan Provincial Science and Technology Agency
- Clinical and Translational Medicine Research Foundation of Chinese Academy of Medical Sciences
- Research and Develop Program, West China Hospital of Stomatology Sichuan University
- Research Funding from West China School/Hospital of Stomatology Sichuan University
Zitieren
APA
Yuan, P., Jiang, S., Wang, Q., Wu, Y., Jiang, Y., Xu, H., Jiang, L., & Luo, X. (2024). Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma. PeerJ. https://doi.org/10.7717/peerj.17296
Vancouver
Yuan P, Jiang S, Wang Q, Wu Y, Jiang Y, Xu H, et al. Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma. PeerJ. 2024. doi:10.7717/peerj.17296
BibTeX
@article{Yuan2024,
author = {Yuan, Peiyang and Jiang, Sixin and Wang, Qiuhao and Wu, Yuqi and Jiang, Yuchen and Xu, Hao and Jiang, Lu and Luo, Xiaobo},
title = {Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.17296}
}
EUVIMED